logo
Cullinane says families dealing with child scoliosis ‘betrayed' by Harris

Cullinane says families dealing with child scoliosis ‘betrayed' by Harris

BreakingNews.ie3 hours ago
Simon Harris cannot say he did everything he could for the family of a child who died after dealing with delays for scoliosis surgery, Sinn Féin has said.
Sinn Féin health spokesman David Cullinane has criticised the Tánaiste over his time dealing with child spinal surgeries as health minister and subsequent time in Government.
Advertisement
It comes amid renewed focus on the waiting-list crisis following the death of nine-year-old Harvey Morrison, who suffered from scoliosis, on July 29th.
Mr Cullinane's remarks came after Fine Gael minister Paschal Donohoe said his party leader 'did all he could' in engaging with health officials over the issue.
Harvey's parents, Gillian Sherratt and Stephen Morrison, learned last August that Harvey had been removed from Children Health Ireland's (CHI) scoliosis waiting list without their knowledge.
After they publicly raised their son's case, Harvey, from Clondalkin, received spinal surgery last December after waiting for years.
Advertisement
By then, his spinal curve had reached the point where it could not be fully corrected.
Sinn Féin health spokesman David Cullinane (Cillian Sherlocl/PA)
While he spent years on a waiting list, his spinal curve caused his rib cage to twist around his lungs and heart, severely restricting his breathing.
While health minister in 2017, Mr Harris pledged that no child would wait more than four months for scoliosis treatment.
Harvey's mother and father have called for the Tánaiste's resignation, further criticising Mr Harris for not personally meeting with them prior to the death of their child.
Advertisement
On Wednesday, Mr Donohoe said: 'Minister Harris, as minister and then as taoiseach and Tánaiste, when he became aware of the needs of the particular family in question here, did all he could in terms of engaging with the Department of Health, in terms of engaging with the HSE.'
Asked about those comments, Mr Cullinane told reporters on Thursday: 'I don't believe that Simon Harris can hold his head up and say he did everything he could.
'Because if he did, children would not be waiting longer than four months, he would have met the family and he would have ensured that whatever was necessary was being done to ensure Harvey got quicker access to care, that that was properly and fully communicated back to the family themselves, and that never happened.'
Mr Cullinane said the family felt 'abandoned' as Mr Harris had not previously met with them.
Advertisement
He added: 'So I believe that the sense of betrayal that they feel is heartfelt on their part and is justified on their part, given everything that I've seen over the last number of years.'
Mr Cullinane said other families experiencing long waits for child spinal surgeries felt a 'sense of betrayal' from Mr Harris and the Government.
A spokesman for the Tánaiste said he spoke with Ms Sherratt on Wednesday and they agreed to meet 'in the near future'.
He has also sought a full multidisciplinary report on the timeline of care provided to Harvey.
Advertisement
In a social media post, Ms Sherratt said she had tentatively agreed to meet Mr Harris but no date had been set.
She said: 'We will have a specific list of things we will be demanding to protect the children that are still here and still depending on CHI Ireland for care.
'We won't accept anything less than what we are asking. Harvey had to compromise on his care for the entirety of his life and we won't be accepting any compromises now.
'We will continue to call for his resignation until such time that we have secured confirmation that these terms are being met.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hack at UnitedHealth's tech unit impacted 192.7 million people, US health dept website shows
Hack at UnitedHealth's tech unit impacted 192.7 million people, US health dept website shows

Reuters

time16 minutes ago

  • Reuters

Hack at UnitedHealth's tech unit impacted 192.7 million people, US health dept website shows

Aug 14 (Reuters) - The cyberattack at UnitedHealth Group's (UNH.N), opens new tab tech unit last year impacted 192.7 million people, the U.S. health department's website showed on Thursday. In January, the company had estimated the hack at Change Healthcare affected the personal information of 190 million people. The cyberattack — the largest healthcare data breach in the United States to date — was disclosed in February last year. The unit was infiltrated by hackers who identified themselves as the "Blackcat" ransomware group, causing widespread disruptions in claims processing and impacting patients and providers across the country. The number of impacted people was posted on a list of data breaches maintained by the U.S. Department of Health and Human Services' office for civil rights. UnitedHealth did not immediately respond to a Reuters request for comment. Information made vulnerable in the UnitedHealth attack is believed to include health insurance member IDs, patient diagnoses, treatment information and social security numbers, as well as billing codes used by providers.

Eli Lilly ramps up UK price of weight loss jab Mounjaro after Trump demands
Eli Lilly ramps up UK price of weight loss jab Mounjaro after Trump demands

The Guardian

timean hour ago

  • The Guardian

Eli Lilly ramps up UK price of weight loss jab Mounjaro after Trump demands

The price of the weight loss jab Mounjaro will rise by up to 170% in the UK, its US manufacturer has said, as Donald Trump ramps up pressure on drugmakers to increase their prices for Europeans so that they can make them more affordable for Americans. Eli Lilly has said it will increase the price of the drug from September, with a month's supply of the highest dose rising from £122 to £330. Mounjaro contains tirzepatide and is self-administered in once-a-week injections. When it launched in Britain in February 2024, Eli Lilly agreed to a list price 'significantly below' its other European markets to stop delays in availability of the medicine through the NHS. The increase in the list price will align it 'more consistently', the company said, although it added the NHS would not pay the new higher price to ensure continued access for the people with obesity and type 2 diabetes receiving it through the health service. Eli Lilly said it was working with private healthcare providers, which could negotiate their own confidential discounts with the company. Trump has threatened to use 'every tool in our arsenal' to crack down on pharmaceutical companies charging higher prices in the US compared with other nations. The US pays about three times more for drugs compared with other developed countries, according to the Rand Corporation thinktank. On 31 July, Trump sent letters to 17 of the world's biggest drugmakers, including Eli Lilly and Novo Nordisk, demanding cuts to drug prices for Americans within 60 days. 'Make no mistake: a collaborative effort towards achieving global pricing parity would be the most effective path for companies, the government and American patients,' Trump wrote. 'But if you refuse to step up we will deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices. 'Americans are demanding lower drug prices, and they need them today.' In May, Trump told reporters that a friend in London had told him he had bought the 'fat shot drug' for $88, compared with $1,300 in New York. Pharmaceutical companies have cashed in on huge demand for weight loss treatments. Denmark's Novo Nordisk has become one of the most prominent names in the field, launching Wegovy in the UK in September 2023, turning it into one of the most valuable companies in Europe. While the jabs have increased profits at big pharmaceutical companies, they are racing to develop an equivalent pill, which would be a more convenient and cheaper alternative for patients and healthcare authorities. Eli Lilly said this month that a pill in early trial stages showed that participants on their highest dose lost an average of 12.4% of their body weight, compared with 0.9% of the control group. Novo Nordisk has submitted its oral weight loss drug for approval in the US. Its trial results showed that participants could lose about 15% of their body weight.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store